Profusa (PFSA) Research & Development (2024 - 2026)

Profusa posted quarterly Research & Development of $1.1 million for Q1 2026, up 164.06% year-on-year from $434000.0 in Q1 2025, and down 8.69% on a QoQ basis from $1.3 million in Q4 2025.

Profusa (PFSA) has 3 years of Research & Development data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 164.06% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (changed N/A YoY), and the FY2025 full-year result was $2.8 million, up 74.38% from the prior year.
  • Research & Development for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $1.3 million in Q4 2025 and bottomed at $259000.0 in Q4 2024.
  • The 3-year median for Research & Development is $578000.0 (2025), against an average of $704500.0.
  • Peak annual rise in Research & Development reached 384.56% in 2025, while the deepest fall reached 75.67% in 2025.
  • A 3-year view of Research & Development shows it stood at $259000.0 in 2024, then surged by 384.56% to $1.3 million in 2025, then fell by 8.69% to $1.1 million in 2026.
  • The last three Research & Development figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $722000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 767.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 413.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 722.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 263.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -461.27 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 345.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.80 Mn
10 Profusa 574,294.01 574,294.01 - 1.15 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.15 Mn
Dec 31, 2025 1.26 Mn
Sep 30, 2025 722,000.00
Dec 31, 2024 259,000.00
Sep 30, 2024 411,000.00